European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Genetic analysis, linkage, and association<br />
Domaine de la Merci, Université Joseph Fourrier, Grenoble, France, 3 Inserm,<br />
U758, Lyon, France, 4 Ecole Normale Supérieure de Lyon, Unité de Virologie<br />
Humaine, IFR 128, Lyon, France, 5 Inserm U309, Institut Albert Bonniot, Grenoble,<br />
France, 6 Laboratoire d’analyse médicales, Rabat, Morocco, 7 Centre privé<br />
de Fécondation In vitro, Rabat, Morocco.<br />
An estimated 80 million people face reproductive difficulties worldwide.<br />
An important proportion of these cases is believed to be caused by<br />
genetic defects, yet few genes have formally been associated with<br />
infertility in the human. We performed a genome-wide microsatellite<br />
scan on 14 unrelated infertile men, all originating from North Africa and<br />
born from first degree cousin. All presented very characteristic sperm<br />
parameters with close to 100% abnormal spermatozoa with anomalies<br />
of the head, several flagellae and polyploidy. A common homozygous<br />
region harboring the Aurora Kinase C gene (AURKC) known to be<br />
highly expressed in the testis and involved in cytokinesis and mitosis/<br />
meiosis was detected in 10/14 patients. Sequence analysis of AURKC<br />
coding sequence showed the presence of a homozygous single nucleotide<br />
deletion in all 14 patients. This mutation results in premature<br />
termination of translation thus yielding a truncated protein which lacks<br />
its kinase domain. We conclude that the absence of AURKC leads<br />
to male infertility due to the production of «large-headed multiflagella<br />
spermatozoa».<br />
P1002. The study of Insulin, Igf2 and NAIP mutations in<br />
romanian population<br />
L. Dumitrescu1 , P. Apostol1 , D. Cimponeriu1 , M. Stavarachi1 , M. Toma1 , D.<br />
Cheta2 , L. Gavrila1 ;<br />
1 2 Institute of <strong>Genetics</strong>, Bucharest, Romania, Institute of Diabetes, Nutrition and<br />
Metabolic Diseases “Nicolae Paulescu”, Bucharest, Romania.<br />
The balance between proliferation and apoptotic processes is involved<br />
in some pathologic phenotype, including type 1 diabetes mellitus<br />
(T1DM), type 2 diabetes mellitus (T2DM) and obesity. The genetic<br />
markers from IDDM2 region were associated with these phenotypes.<br />
Neuronal apoptosis inhibitory protein (NAIP, 5q) was found also to<br />
have anti-apoptotic effects in different cells and to be up-regulated during<br />
adipocytes differentiation.<br />
The aims of our study were to test the contribution of Insulin, IGF2 and<br />
NAIP polymorphisms to diabetes onset and obesity.<br />
Clinical information and blood samples were collected from unrelated<br />
obese T2DM subjects (n=70, BMI between 32,5-39 kg/m2), nonobese<br />
T1DM (n=70, BMI between 20-25kg/m2) and 150 controls (non obese,<br />
non-diabetic subjects). All samples were genotyped for Insulin -23Hph,<br />
Insulin +1127Pst1, IGF2Apa and NAIP exon 5 polymorphisms.<br />
We observed a higher frequency (4%) of NAIP exon 5 homozygous<br />
deletion in control group compared with obese T2DM (2,85%) and<br />
T1DM (1,42%) patients. This value is also higher than in other populations.<br />
Interesting, all subjects with homozygous absence of NAIP exon<br />
5 have low BMI .The IGF2 AA genotype was more frequent in T2DM<br />
comparing with T1DM and control subjects (OR=1,9) and polymorphisms<br />
from insulin region (OR-23Hph AA= 2,7, OR +1127Pst CC =<br />
2,0983) were more frequent in T1DM subjects.<br />
Taken together, we found a high frequency of -23Hph AA and +1127Pst<br />
CC in T1DM patients, of IGF2 AA in T2DM and of NAIP exon 5 homozygous<br />
deletion in control group.<br />
P1003. Analysis of IGF1 gene polymorphism in newborn and<br />
elderly people from North-West region of Russia<br />
S. V. Potulova 1 , O. S. Glotov 2 , V. G. Vakharlovsky 2 , O. N. Bespalova 2 , T. E.<br />
Ivaschenko 2 , V. S. Baranov 2,1 ;<br />
1 Saint-Petersburg State University, St-Petersburg, Russian Federation, 2 Ott’s Institute<br />
of Obstetrics and Gynecology RAMS, St-Petersburg, Russian Federation.<br />
The serum insulin growth factor IGF-1 level differs in various human<br />
ages. The individual variations in the level of this enzyme depend on<br />
the number of CA repeats in the promoter region of IGF-1 gene. In this<br />
study IGF-1 (CA repeats) gene polymorphism was analyzed by PCR<br />
method in 102 newborns and also in 136 elderly people from North-<br />
West Region of Russia. Increasing of the frequency of 20/- genotype<br />
in elderly people when compared to newborn group (26.7%, 44.1%,<br />
respectively, p=0.0034) with concomitant age-related decrease of<br />
<strong>19</strong>/<strong>19</strong> genotype frequency (51%, 27.9%, respectively, p=0.0001) were<br />
found. According our data <strong>19</strong>/20 genotype in male newborns was twice<br />
more frequent than in female ones (23.2%, 11.3%). The same ration<br />
remained constant in elderly people as well but the proportion of <strong>19</strong>/20<br />
genotype in this group increased almost twice (44.4%, 21.1%, respectively,<br />
p=0.025). The association of 20CA allele with lower body weight<br />
(Z=2.2, p=0.028) and reduced height in female newborns has been<br />
registered. We suggest that increased number of CA repeats (more<br />
than 20 CA) being responsible for low production of IGF-1 enzyme is<br />
associated with longevity in man as well as with reduced body weight<br />
and the height in female newborns. Allele <strong>19</strong> responsible for the high<br />
level of serum IGF-1 might be associated with longevity for women.<br />
Our final finding was the correlation between 20 CA allele of IGF-1 and<br />
cataract (Z=2.4, p=0.018). There was no correlation between IGF-1<br />
gene polymorphism and stroke, essential hypertension, coronary heart<br />
disease and Type 2 diabetes.<br />
P1004. Interleukin-23 receptor (IL23R) gene C2370A<br />
polymorphism in scleroderma patients<br />
E. Sáfrány 1 , B. Faragó 1 , V. Csöngei 1 , L. Magyari 1 , A. Maász 1 , C. Sipeky 1 , L.<br />
Járomi 1 , K. Horvatovich 1 , J. Radics 2 , L. Czirják 2 , B. Melegh 1 ;<br />
1 Department of Medical <strong>Genetics</strong> and Child Development, University of Pécs,<br />
Pécs, Hungary, 2 Department of Immunology and Rheumatology, University of<br />
Pécs, Pécs, Hungary.<br />
Scleroderma or systemic sclerosis is a chronic connective tissue<br />
disease generally classified as one of the autoimmune rheumatic<br />
diseases. The cause of scleroderma is still unknown but there are<br />
several factors presumed: abnormal immune or inflammatory activity<br />
stimulating the fibroblasts to produce too much collagen, as well<br />
as not yet discovered genetic and enviromental factors. Interleukin-<br />
23 plays an important role in the Th17 mediated immune response.<br />
The IL23R gene located on chromosome 1p31 encodes a subunit of<br />
the IL23-receptor. Recent investigations (Duerr et al, Science, 2006;<br />
314:1461-1463) identified several IL23R gene polymorphisms as risk<br />
factors for inflammatory bowel diseases. Theoretical considerations<br />
also suggested possible association of these SNPs with other autoimmune<br />
diseases. Our aim was to test whether the 3’-UTR C2370A SNP<br />
of the IL23R gene (rs10889677), one of the verified IBD susceptibility<br />
genes also confers risk for scleroderma. We performed genotyping<br />
using DNA samples collected from 244 patients with scleroderma and<br />
135 unrelated, healthy controls. The genotypes were analysed using<br />
PCR/RFLP-methods. We found no significant difference between the<br />
allele frequencies of the two groups (73% and 71% for the C allele<br />
and 27% and 29% for the A allele in patients with scleroderma and in<br />
the control group, respectively). Our results show that eventhough the<br />
C2370A polymorphism of IL23R can associate with selected autoimmune<br />
diseases like the Crohn’s disease, but not with others, including<br />
the scleroderma, thereby it is not an universal autoimmune disease<br />
associated susceptibility factor.<br />
P1005. Interleukin-23 receptor 3‘-UTR C2370A SNP confers risk<br />
for rheumatoid arthritis<br />
B. Faragó 1 , L. Magyari 1 , V. Csöngei 1 , L. Járomi 1 , E. Sáfrány 1 , K. Horvatovich 1 ,<br />
C. Sipeky 1 , A. Maász 1 , J. Radics 2 , L. Czirják 2 , B. Melegh 1 ;<br />
1 Department of Medical <strong>Genetics</strong> and Child Development, University of Pécs,<br />
Pécs, Hungary, 2 Department of Immunology and Rheumatology, University of<br />
Pécs, Pécs, Hungary.<br />
INTRODUCTION: Interleukin-23 (IL23) is a proinflammatory cytokine<br />
that plays a crucial role in the development of chronic inflammation,<br />
being a master regulator of the IL17/23 molecular pathway. IL23-receptor<br />
gene (IL23R) on chromosome 1p31 encodes one subunit of<br />
the IL23-receptor. Duerr et al. (Science, 2006; 314:1461-1463) using<br />
genome-wide association study found association between Crohn’s<br />
disease and the IL23R gene; amongst the reported SNPs the 3’-UTR<br />
C2370A (rs10889677) conferred risk for Crohn’s disease in a non-Jewish<br />
population. Since the IL17/23 pathway is known to associate with<br />
experimental allergic encephalomyelitis, inflammatory bowel disease,<br />
multiple sclerosis, collagen-induced arthritis, rheumatoid arthritis (RA),<br />
and perhaps other autoimmune diseases, we theoretized that this SNP<br />
described originally for Crohn’s disease might also have significance<br />
in the development of RA. Therefore, the aim of the present study was<br />
to test this hypothesis. METHODS: Genotyping was performed on 226<br />
well-characterized RA-patients and 135 age-and sex-matched controls<br />
using a PCR-RFLP method. All RA-patients were characterized<br />
for RF- and anti-CCP seropositivity. RESULTS: We observed a highly<br />
increased prevalence of the homozygous AA genotype compared to<br />
the controls (15.0% vs. 4.44%; p